Fox Run Management’s NovoCure NVCR Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $361K | Buy |
+20,288
| New | +$361K | 0.06% | 588 |
|
|
2024
Q4 | – | Sell |
-32,451
| Closed | -$507K | – | 1081 |
|
|
2024
Q3 | $507K | Buy |
+32,451
| New | +$507K | 0.11% | 351 |
|
|
2024
Q2 | – | Sell |
-15,809
| Closed | -$247K | – | 980 |
|
|
2024
Q1 | $247K | Sell |
15,809
-10,415
| -40% | -$163K | 0.05% | 580 |
|
|
2023
Q4 | $392K | Buy |
26,224
+6,840
| +35% | +$102K | 0.1% | 392 |
|
|
2023
Q3 | $313K | Buy |
+19,384
| New | +$313K | 0.09% | 428 |
|
|
2018
Q2 | – | Sell |
-10,597
| Closed | -$231K | – | 837 |
|
|
2018
Q1 | $231K | Buy |
+10,597
| New | +$231K | 0.06% | 584 |
|
|
2017
Q4 | – | Sell |
-23,200
| Closed | -$461K | – | 813 |
|
|
2017
Q3 | $461K | Buy |
23,200
+10,200
| +78% | +$203K | 0.13% | 321 |
|
|
2017
Q2 | $225K | Buy |
+13,000
| New | +$225K | 0.08% | 510 |
|